Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 24
1946 135
1947 144
1948 176
1949 148
1950 188
1951 161
1952 189
1953 169
1954 181
1955 176
1956 168
1957 207
1958 181
1959 192
1960 205
1961 194
1962 206
1963 226
1964 263
1965 241
1966 258
1967 247
1968 232
1969 265
1970 258
1971 279
1972 285
1973 253
1974 302
1975 282
1976 291
1977 297
1978 308
1979 309
1980 339
1981 379
1982 456
1983 481
1984 561
1985 541
1986 505
1987 549
1988 567
1989 508
1990 554
1991 667
1992 629
1993 625
1994 493
1995 441
1996 463
1997 279
1998 371
1999 515
2000 380
2001 353
2002 345
2003 406
2004 410
2005 434
2006 506
2007 459
2008 440
2009 344
2010 360
2011 326
2012 321
2013 372
2014 320
2015 357
2016 335
2017 317
2018 306
2019 271
2020 312
2021 275
2022 143
Text availability
Article attribute
Article type
Publication date

Search Results

24,904 results
Results by year
Filters applied: . Clear all
Page 1
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial.
Sarraju A, Li J, Cannon CP, Chang TI, Agarwal R, Bakris G, Charytan DM, de Zeeuw D, Greene T, Heerspink HJL, Levin A, Neal B, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Perkovic V, Jardine M, Mahaffey KW. Sarraju A, et al. Am Heart J. 2021 Mar;233:141-148. doi: 10.1016/j.ahj.2020.12.008. Epub 2020 Dec 22. Am Heart J. 2021. PMID: 33358942 Clinical Trial.
Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trial.
Lopes RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, Ramacciotti E, Damini LP, Bronhara B, Cavalcanti AB, Rosa RG, Azevedo LCP, Veiga VC, Machado FR, Ritt LE, Martins PA, Alexander JH, Avezum A, Berwanger O; Coalition COVID-19 Brazil IV Investigators. Lopes RD, et al. Am Heart J. 2021 Aug;238:1-11. doi: 10.1016/j.ahj.2021.04.005. Epub 2021 Apr 20. Am Heart J. 2021. PMID: 33891907 Free PMC article. Clinical Trial.
Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial.
Ramacciotti E, Agati LB, Calderaro D, Volpiani GG, de Oliveira CCC, Aguiar VCR, Rodrigues E, Sobreira ML, Joviliano EE, Dusilek C, Itinose K, Dedivitis RA, Cortina AS, Sanches SMV, de Moraes NF, Tierno PFGMM, de Oliveira ALML, Tachibana A, Chate RC, Santos MVB, Cavalcante BBM, Moreira RCR, Chiann C, Tafur A, Spyropoulos AC, Lopes RD. Ramacciotti E, et al. Am Heart J. 2021 Dec;242:115-122. doi: 10.1016/j.ahj.2021.08.016. Epub 2021 Sep 1. Am Heart J. 2021. PMID: 34480880 Free PMC article. Clinical Trial.
24,904 results
You have reached the last available page of results. Please see the User Guide for more information.